CDKN2B and gastric cancer: Alterations in TP53, KRAS, ARID1A, and APC in gastric cancer patients and alterations in KRAS, TP53, SMAD4, CDKN2A, and CDKN2B in pancreatic cancer patients were observed (Table 2).